Disclosure statement
This study is being conducted as a research collaboration with Alnylam Pharmaceuticals. Yoshiki Sekijima received speaker honoraria from Alnylam Pharmaceuticals and Pfizer.
This study is being conducted as a research collaboration with Alnylam Pharmaceuticals. Yoshiki Sekijima received speaker honoraria from Alnylam Pharmaceuticals and Pfizer.
PDF download + Online access
Issue Purchase
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more